Skip to content
Inciteful Med

Staying Ahead: Your Long-Term Health Plan

Last updated:

Proactive, lifelong monitoring is essential for people with Myotonic Dystrophy Type 1 (DM1) to detect silent complications early. A comprehensive health plan includes annual heart monitors, regular lung function tests, and routine screenings for cataracts and endocrine issues.

Key Takeaways

  • • Lifelong surveillance is critical in DM1 to catch silent heart and lung complications early.
  • • Annual 24-hour Holter monitors are essential because routine ECGs can miss dangerous, intermittent heart rhythm issues.
  • • Regular pulmonary function tests help determine when non-invasive breathing support like BiPAP is needed.
  • • Routine screenings should also check for early-onset cataracts, insulin resistance, and thyroid dysfunction.
  • • Connecting with patient groups and practicing self-advocacy are vital for managing the mental and emotional aspects of chronic disease.

Because Myotonic Dystrophy Type 1 (DM1) can affect systems that don’t always show obvious symptoms—like the heart and lungs—proactive, lifelong monitoring is your most powerful tool for maintaining your health [1][2]. The goal of surveillance is to detect “silent” changes early, when they are most manageable, and to prevent the leading causes of complications in DM1: heart rhythm issues and respiratory weakness [3][4].

Your Surveillance Schedule

Expert consensus recommendations, such as those from the Myotonic Dystrophy Foundation (MDF), provide a roadmap for what high-quality monitoring looks like [5].

System Test Frequency Why it matters
Heart ECG & 24-hour Holter Annual [6] Detects “silent” rhythm or conduction delays [7].
Heart Echocardiogram At diagnosis; periodic [1] Monitors heart pump strength and structure [8].
Lungs PFT (FVC, MIP/MEP) Every 6–12 months [9] Tracks breathing muscle strength [10][11].
Sleep Sleep Study (Polygraphy) At diagnosis; as needed [12] Screens for sleep apnea or nocturnal hypoventilation [13].
Eyes Slit-lamp exam Every 1–2 years [5] Checks for early-onset cataracts [14][15].
Endocrine HbA1c / Fasting Glucose Annual [5] Screens for insulin resistance or diabetes [16][17].
Endocrine Thyroid (TSH/T4) Annual [5] Monitors for thyroid dysfunction [18][19].

Managing “Silent” Risks

The two most critical areas for long-term safety are the heart and the respiratory system [3][4].

  • Heart Health: Up to 75% of adults with DM1 develop conduction defects [20]. Because a routine ECG only captures a few seconds of your heart’s rhythm, a 24-hour Holter monitor is essential for catching issues that come and go [7][21].
  • Breathing Support: Respiratory failure is the most common cause of death in DM1 [4][3]. Tracking your Forced Vital Capacity (FVC) allows your team to intervene with Non-Invasive Ventilation (NIV/BiPAP) before you experience a crisis [9][22].

Empowered Survivorship

Living with a chronic condition requires mental and emotional resilience. It is common to experience “scan anxiety” or feel overwhelmed by frequent appointments [23].

  • Connect with a Community: Consider connecting with organizations like the Myotonic Dystrophy Foundation (MDF). Joining a patient registry or support group can help you find a community, stay informed about clinical trials, and feel less isolated [5].
  • Self-Advocacy: Always carry your Medical Emergency Card [24]. In any medical setting, remind your providers about the specific risks of anesthesia and the importance of monitoring your heart and breathing [25][5].
  • Symptom Tracking: Keep a simple log of how you feel. Note any new heart flutters, morning headaches (a sign of poor sleep breathing), or changes in your energy levels [13][26].
  • Mental Health: Don’t ignore the psychological impact of DM1. Cognitive Behavioral Therapy (CBT) has been shown to help patients manage fatigue and stay socially engaged [27][28].

Remember, you are the most important member of your care team. Proactive monitoring isn’t just about “checking for problems”—it’s about empowering yourself to live as fully and safely as possible [29][30].

Frequently Asked Questions

Why do I need a 24-hour Holter monitor if my regular ECG is normal?
A routine ECG only records your heart rhythm for a few seconds. Because adults with DM1 often develop heart rhythm issues that come and go, a 24-hour Holter monitor is needed to catch these silent problems before they become dangerous.
How often should my lung function be tested if I have DM1?
Experts recommend having pulmonary function tests every 6 to 12 months. Tracking your breathing muscle strength allows your doctor to prescribe non-invasive ventilation, like BiPAP, before you experience a respiratory crisis.
What are the warning signs of breathing problems during sleep?
Waking up with morning headaches, daytime fatigue, or finding it difficult to take a deep breath when lying down are key warning signs. These symptoms suggest poor sleep breathing and may mean you need a sleep study.
What other routine tests do I need besides heart and lung monitoring?
In addition to your heart and lungs, you should have your eyes checked every one to two years for early-onset cataracts. Annual blood tests are also needed to monitor your thyroid function and screen for insulin resistance or diabetes.

Questions for Your Doctor

  • • Which specialized center or multidisciplinary team will oversee my long-term monitoring?
  • • If my ECG is normal, why do I still need an annual 24-hour Holter monitor and echocardiogram?
  • • At what specific decline in my lung function (FVC) will we need to discuss starting nocturnal ventilation (BiPAP)?
  • • How will we monitor my thyroid and blood sugar levels, and how often?
  • • Are there local resources or therapists you recommend for managing the stress of chronic illness monitoring?

Questions for You

  • • Have you noticed any new 'skips' or 'flutters' in your heartbeat, or felt unusually lightheaded recently?
  • • Do you find it harder to take a deep breath when lying flat, or have you been waking up with morning headaches?
  • • How do you currently track your symptoms—would a simple journal or a phone app help you stay organized for your doctor visits?
  • • What is your biggest concern when you think about your long-term health with DM1?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value.

    Russo V, Capolongo A, Bottino R, et al.

    Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051947.

    PMID: 36902735
  2. 2

    Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.

    Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al.

    Neurologia 2020; (35(3)):185-206 doi:10.1016/j.nrl.2019.01.001.

    PMID: 31003788
  3. 3

    Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

    Wu S, Prahlow JA

    The American journal of forensic medicine and pathology 2025; (46(4)):330-336 doi:10.1097/PAF.0000000000001073.

    PMID: 40928346
  4. 4

    Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.

    Gallinoro E, Papa AA, Rago A, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(3)):227-231.

    PMID: 30838353
  5. 5

    Consensus-based care recommendations for adults with myotonic dystrophy type 1.

    Ashizawa T, Gagnon C, Groh WJ, et al.

    Neurology. Clinical practice 2018; (8(6)):507-520 doi:10.1212/CPJ.0000000000000531.

    PMID: 30588381
  6. 6

    [Myotonic dystrophy type 1 - a rare cause of bradycardia in the young].

    Kataja Knight A, Tidehag L, Mattsson G, Magnusson P

    Lakartidningen 2020; (117()).

    PMID: 31961442
  7. 7

    An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.

    Joosten IBT, Janssen CEW, Horlings CGC, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2023; (25(1)):156-163 doi:10.1093/europace/euac104.

    PMID: 35851806
  8. 8

    Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.

    Park JS, Kim N, Park D

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2018; (39(11)):1935-1943 doi:10.1007/s10072-018-3530-z.

    PMID: 30094526
  9. 9

    Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

    Mazzoli M, Ariatti A, Garuti G, et al.

    Acta neurologica Belgica 2021; (121(1)):133-142 doi:10.1007/s13760-020-01425-z.

    PMID: 32651874
  10. 10

    Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1.

    Hartog L, Zhao J, Reynolds J, et al.

    Frontiers in neurology 2021; (12()):658532 doi:10.3389/fneur.2021.658532.

    PMID: 33927684
  11. 11

    Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders.

    Wenninger S, Stahl K, Wirner C, et al.

    Neuromuscular disorders : NMD 2020; (30(8)):640-648 doi:10.1016/j.nmd.2020.06.009.

    PMID: 32690350
  12. 12

    Evaluation of Sleep-Disordered Breathing and Respiratory Dysfunction in Children with Myotonic Dystrophy Type 1-A Retrospective Cross-Sectional Study.

    Basa M, Pesovic J, Savic-Pavicevic D, et al.

    Biomedicines 2025; (13(4)) doi:10.3390/biomedicines13040966.

    PMID: 40299556
  13. 13

    Sleep-disordered breathing and effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with myotonic dystrophy type I.

    Spiesshoefer J, Runte M, Heidbreder A, et al.

    Neuromuscular disorders : NMD 2019; (29(4)):302-309 doi:10.1016/j.nmd.2019.02.006.

    PMID: 30898523
  14. 14

    Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1.

    Scutifero M, Lanza M, Petillo R, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2022; (41(3)):105-110 doi:10.36185/2532-1900-N75.

    PMID: 36349183
  15. 15

    Myotonic Muscular Dystrophies.

    Johnson NE

    Continuum (Minneapolis, Minn.) 2019; (25(6)):1682-1695 doi:10.1212/CON.0000000000000793.

    PMID: 31794466
  16. 16

    Therapeutic advances in type 1 myotonic dystrophy complicated with type 2 diabetes mellitus.

    Luo L, Zhu C, Yang S, et al.

    Frontiers in neurology 2025; (16()):1640563 doi:10.3389/fneur.2025.1640563.

    PMID: 41018201
  17. 17

    Asymptomatic myocardial infarction in a patient with myotonic dystrophy type 1.

    Seki Y, Yamada T, Kiyosue A, et al.

    Journal of cardiology cases 2022; (26(4)):248-251 doi:10.1016/j.jccase.2022.05.004.

    PMID: 36187313
  18. 18

    Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.

    Spaziani M, Semeraro A, Bucci E, et al.

    Journal of endocrinological investigation 2020; (43(5)):663-675 doi:10.1007/s40618-019-01156-w.

    PMID: 31786795
  19. 19

    Managing thyroid cancer in Steinert's disease: the role of radiofrequency ablation.

    Solis-Pazmino P, Carvajal MA, García M, et al.

    Journal of surgical case reports 2023; (2023(6)):rjad381 doi:10.1093/jscr/rjad381.

    PMID: 37397070
  20. 20

    Cardiac Pathology in Myotonic Dystrophy Type 1.

    Mahadevan MS, Yadava RS, Mandal M

    International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111874.

    PMID: 34769305
  21. 21

    Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.

    Gamet A, Degand B, Le Gal F, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2019; (24(1)):e12587 doi:10.1111/anec.12587.

    PMID: 30101452
  22. 22

    New Insights in Adherence and Survival in Myotonic Dystrophy Patients Using Home Mechanical Ventilation.

    Seijger C, Raaphorst J, Vonk J, et al.

    Respiration; international review of thoracic diseases 2021; (100(2)):154-163 doi:10.1159/000511962.

    PMID: 33461194
  23. 23

    Diabetes distress and diabetes burnout explored in various areas of life in patients with type 1 diabetes: effect of short-term psychological intervention.

    Cyranka K, Klupa T, Pilecki M, et al.

    Endocrine 2024; (85(2)):676-684 doi:10.1007/s12020-024-03760-0.

    PMID: 38448676
  24. 24

    [Medical emergency card for Steinert's disease: an unmet need].

    Rosado-Bartolomé A, Domínguez-González C

    Revista de neurologia 2023; (76(1)):15-19 doi:10.33588/rn.7601.2022380.

    PMID: 36544372
  25. 25

    Laparoscopic cholecystectomy under total intravenous anaesthesia in a patient with myotonic dystrophy type 1 (Steinert's disease) - a case report.

    Karras G, Nikouli E, Kiamiloglou B

    Folia medica 2022; (64(2)):333-336 doi:10.3897/folmed.64.e59905.

    PMID: 35851789
  26. 26

    Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.

    Sansone VA, Proserpio P, Mauro L, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(12)):2383-2391 doi:10.5664/jcsm.9438.

    PMID: 34170223
  27. 27

    Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

    Okkersen K, Jimenez-Moreno C, Wenninger S, et al.

    The Lancet. Neurology 2018; (17(8)):671-680 doi:10.1016/S1474-4422(18)30203-5.

    PMID: 29934199
  28. 28

    Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

    Miller JN, Kruger A, Moser DJ, et al.

    Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.

    PMID: 34276551
  29. 29

    Myotonic dystrophy type 2: the 2020 update.

    Meola G

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.

    PMID: 33458578
  30. 30

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483

This page provides long-term monitoring guidelines for Steinert myotonic dystrophy (DM1) for educational purposes. Always consult your multidisciplinary healthcare team to tailor a surveillance plan to your specific needs.

Stay up to date

Get notified when new research about Steinert myotonic dystrophy is published.

No spam. Unsubscribe anytime.